MDM2 and Miyoshi myopathy: The inhibition of the MDM2-TP53 interaction by nutlin-3A is an attractive strategy to stabilize the P53 mediated apoptosis in various WT TP53 tumors, including MM (42–44), and therefore worth investigating.